Nu Skin Enterprises (NUS) PT Raised to $7.50 at DA Davidson

DA Davidson analyst Linda Bolton Weiser raised the price target on Nu Skin Enterprises (NYSE: NUS) to $7.50 (from $7.00) while maintaining a Neutral rating.

The analyst comments "NEUTRAL-rated NUS reported a 4Q24 EPS beat vs. consensus, with CC sales -4.7%, exceeding our estimate of -9.4%. China and Korea remain under pressure. The company plans to launch a new iO device in 2H25. We think NUS faces structural challenges in reversing industry headwinds without a truly differentiated product to drive sustainable demand. The rate of organic sales decline moderated in 2024, and management expects a recovery in certain markets in 2025. But there is still no clear visibility on when the company can return to growth. We are raising our PT by $0.50 to $7.50, based on 4x our 2026E EBITDA of $163M (raised from $151M)."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)
• Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters